Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 411

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion

Open access
Voli, Florida, Valli, Emanuele, Lerra, Luigi, Kimpton, Kathleen, Saletta, Federica, Giorgi, Federico M., Mercatelli, Daniele, Rouaen, Jourdin R.C., Shen, Sylvie, Murray, Jayne E., Ahmed-Cox, Aria, Cirillo, Giuseppe, Mayoh, Chelsea, Beavis, Paul A., Haber, Michelle, Trapani, Joseph A., Kavallaris, Maria, Vittorio, Orazio·2020·Cancer Research

Abstract

Therapeutic checkpoint antibodies blocking programmed death receptor 1/programmed death ligand 1 (PD-L1) signaling have radically improved clinical outcomes in cancer. However, the regulation of PD-L1 expression on tumor cells is still poorly understood. Here we show that intratumoral copper levels influence PD-L1 expression in cancer cells. Deep analysis of the The Cancer Genome Atlas database and tissue microarrays showed strong correlation between the major copper influx transporter copper transporter 1 (CTR-1) and PD-L1 expression across many cancers but not in corresponding normal tissues. Copper supplementation enhanced PD-L1 expression at mRNA and protein levels in cancer cells and RNA sequencing revealed that copper regulates key signaling pathways mediating PD-L1–driven cancer immune evasion. Conversely, copper chelators inhibited phosphorylation of STAT3 and EGFR and promoted ubiquitin-mediated degradation of PD-L1. Copper-chelating drugs also significantly increased the number of tumor-infiltrating CD8+ T and natural killer cells, slowed tumor growth, and improved mouse survival. Overall, this study reveals an important role for copper in regulating PD-L1 and suggests that anticancer immunotherapy might be enhanced by pharmacologically reducing intratumor copper levels. Significance: These findings characterize the role of copper in modulating PD-L1 expression and contributing to cancer immune evasion, highlighting the potential for repurposing copper chelators as enhancers of antitumor immunity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-20-0471

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Cited by

See all 411

Metadata

Authors
Voli, F., Valli, E., Lerra, L., Kimpton, K., Saletta, F., Giorgi, F. M., Mercatelli, D., Rouaen, J. R. C., Shen, S., Murray, J. E., Ahmed-Cox, A., Cirillo, G., Mayoh, C., Beavis, P. A., Haber, M., Trapani, J. A., Kavallaris, M., & Vittorio, O.
Venue
Cancer Research
Published
2020-10-01
Volume
80
Issue
19
Pages
4129-4144
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W3076758593
Cited by
411
References
51
FWCI
14.12
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion. https://app.cochat.ai/papers/10.1158/0008-5472.can-20-0471
The paper
Voli, F., Valli, E., Lerra, L., Kimpton, K., Saletta, F., Giorgi, F. M., Mercatelli, D., Rouaen, J. R. C., Shen, S., Murray, J. E., Ahmed-Cox, A., Cirillo, G., Mayoh, C., Beavis, P. A., Haber, M., Trapani, J. A., Kavallaris, M., & Vittorio, O. (2020). Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion. Cancer Research. https://doi.org/10.1158/0008-5472.can-20-0471

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.